Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
+0,25%
1 104,10
+2,73
+0,25%
1 101,371 103,631 105,311 091,41
SIXC
Communications
SIXC
Communications
SIXC
-1,50%
604,16
-9,19
-1,50%
613,35613,35613,35601,49
SIXE
Energy
SIXE
Energy
SIXE
-0,09%
1 197,81
-1,02
-0,09%
1 198,831 199,681 199,751 182,41
SIXI
Industrials
SIXI
Industrials
SIXI
-0,88%
1 740,41
-15,54
-0,88%
1 755,951 754,061 756,031 734,69
SIXM
Financials
SIXM
Financials
SIXM
-0,64%
634,44
-4,07
-0,64%
638,51637,41637,41633,05
SIXR
Staples
SIXR
Staples
SIXR
-0,31%
840,90
-2,62
-0,31%
843,52843,35846,40837,93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,38%
215,13
-0,82
-0,38%
215,95215,95216,84215,06
SIXT
Technology
SIXT
Technology
SIXT
+2,86%
3 228,71
+89,80
+2,86%
3 138,913 189,303 230,853 174,76
SIXU
Utilities
SIXU
Utilities
SIXU
+0,16%
935,87
+1,50
+0,16%
934,37934,72938,26927,50
SIXV
Health care
SIXV
Health care
SIXV
-1,37%
1 457,12
-20,31
-1,37%
1 477,431 474,121 474,121 451,80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,83%
2 399,84
+19,65
+0,83%
2 380,192 389,342 403,042 380,47
AXGN:NASDAQ
AxoGen, Inc Common Stock
39,25 US$
+4,92%
(+1,84) 1K
39,80 US$
+1,40% (+0,55)
Yopilgandan keyin
Savdolar yopilgan: 24-apr, 16:00:01 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
AXGN tikeri uchun statistika yaratilmoqda...
Ochish
37,41 US$
Yuqori
39,52 US$
Past
36,75 US$
Bozor kapitali
2,04 mlrd
Oʻrtacha hajm
1,08 mln
Hajmi
1,51 mln
52 haftalik eng yuqori
39,99 US$
52 haftalik eng past
9,22 US$
Aksiya boʻyicha daromad
-0,34 US$
Beta
0,98
Muomaladagi aksiyalar
51,90 mln
Xodimlar soni
622
Yangiliklar
Internetdagi manbalardan
Profil
Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use. Wikipedia
AxoGen, Inc Common Stock haqida
CEO-
Xodimlar soni622
Asos solingan2002
Bosh ofislarAlachua, Florida, Amerika Qo‘shma Shtatlari
Sektor-
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – USD
mar, 2025
iyn, 2025
sen, 2025
dek, 2025
Daromad
48,56 mln
56,66 mln
60,08 mln
59,90 mln
Sotilgan mahsulotning tannarxi
13,63 mln
14,64 mln
14,09 mln
15,50 mln
Daromad narxi
13,63 mln
14,64 mln
14,09 mln
15,50 mln
Tadqiqot va ishlanmalarga xarajatlar
6,09 mln
6,85 mln
7,56 mln
12,38 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
30,50 mln
33,49 mln
36,52 mln
41,80 mln
Operatsion xarajatlar
36,59 mln
40,35 mln
44,08 mln
54,18 mln
Jami operatsion xarajatlar
50,22 mln
54,99 mln
58,17 mln
69,68 mln
Operatsion daromad
-1,66 mln
1,67 mln
1,91 mln
-9,77 mln
Boshqa nooperatsion daromad
-195,00 ming
659,00 ming
234,00 ming
-2,02 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
-3,83 mln
579,00 ming
708,00 ming
-13,16 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
-3,83 mln
579,00 ming
708,00 ming
-13,16 mln
Daromad soligʻi boʻyicha xarajat
-
-
-
-
Amaldagi soliq stavkasi
-
-
-
-
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
-3,83 mln
579,00 ming
708,00 ming
-13,16 mln
Sof foyda marjasi
-7,90%
1,02%
1,18%
-21,96%
Har bir aksiya foydasi
-0,02
0,12
0,12
0,07
Foizlar va investitsiyalardan olingan daromadlar
272,00 ming
225,00 ming
319,00 ming
352,00 ming
Foizlarni toʻlash xarajatlari
-2,25 mln
-1,98 mln
-1,76 mln
-1,72 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-1,98 mln
-1,75 mln
-1,44 mln
-1,37 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
134,00 ming
3,40 mln
3,64 mln
-8,04 mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil